USTR's move to keep India on IP watch list could hit covid-drug access

Médecins Sans Frontières’ Access Campaign says the Special 301 Report threatens countries like India with sanctions at the behest of pharmaceutical corporations and is aimed at blocking more affordable generic versions of drugs